» Articles » PMID: 32904507

Artificial Intelligence Manages Congenital Cataract with Individualized Prediction and Telehealth Computing

Abstract

A challenge of chronic diseases that remains to be solved is how to liberate patients and medical resources from the burdens of long-term monitoring and periodic visits. Precise management based on artificial intelligence (AI) holds great promise; however, a clinical application that fully integrates prediction and telehealth computing has not been achieved, and further efforts are required to validate its real-world benefits. Taking congenital cataract as a representative, we used Bayesian and deep-learning algorithms to create CC-Guardian, an AI agent that incorporates individualized prediction and scheduling, and intelligent telehealth follow-up computing. Our agent exhibits high sensitivity and specificity in both internal and multi-resource validation. We integrate our agent with a web-based smartphone app and prototype a prediction-telehealth cloud platform to support our intelligent follow-up system. We then conduct a retrospective self-controlled test validating that our system not only accurately detects and addresses complications at earlier stages, but also reduces the socioeconomic burdens compared to conventional methods. This study represents a pioneering step in applying AI to achieve real medical benefits and demonstrates a novel strategy for the effective management of chronic diseases.

Citing Articles

Artificial intelligence virtual assistants in primary eye care practice.

Stuermer L, Braga S, Martin R, Wolffsohn J Ophthalmic Physiol Opt. 2024; 45(2):437-449.

PMID: 39723633 PMC: 11823310. DOI: 10.1111/opo.13435.


Ocular Pathology and Genetics: Transformative Role of Artificial Intelligence (AI) in Anterior Segment Diseases.

Venkatapathappa P, Sultana A, K S V, Mansour R, Chikkanarayanappa V, Rangareddy H Cureus. 2024; 16(2):e55216.

PMID: 38435218 PMC: 10908431. DOI: 10.7759/cureus.55216.


Artificial intelligence and deep learning in ophthalmology: Current status and future perspectives.

Jin K, Ye J Adv Ophthalmol Pract Res. 2023; 2(3):100078.

PMID: 37846285 PMC: 10577833. DOI: 10.1016/j.aopr.2022.100078.


Guidelines for the application of artificial intelligence in the diagnosis of anterior segment diseases (2023).

Shao Y, Jie Y, Liu Z Int J Ophthalmol. 2023; 16(9):1373-1385.

PMID: 37724278 PMC: 10475626. DOI: 10.18240/ijo.2023.09.03.


Artificial Intelligence for Anterior Segment Diseases: A Review of Potential Developments and Clinical Applications.

Xu Z, Xu J, Shi C, Xu W, Jin X, Han W Ophthalmol Ther. 2023; 12(3):1439-1455.

PMID: 36884203 PMC: 10164195. DOI: 10.1007/s40123-023-00690-4.


References
1.
. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

2.
Ting D, Yim-Lui Cheung C, Lim G, Wei Tan G, Quang N, Gan A . Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes. JAMA. 2017; 318(22):2211-2223. PMC: 5820739. DOI: 10.1001/jama.2017.18152. View

3.
Youden W . Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. DOI: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. View

4.
Obermeyer Z, Emanuel E . Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016; 375(13):1216-9. PMC: 5070532. DOI: 10.1056/NEJMp1606181. View

5.
Kermany D, Goldbaum M, Cai W, Valentim C, Liang H, Baxter S . Identifying Medical Diagnoses and Treatable Diseases by Image-Based Deep Learning. Cell. 2018; 172(5):1122-1131.e9. DOI: 10.1016/j.cell.2018.02.010. View